Prograf is a prescription medication that contains the active ingredient tacrolimus. It is supplied as a pill in strengths of 0.5 mg, 1 mg, and 5 mg. Tacrolimus belongs to the class of immunosuppressants and is primarily used to prevent organ rejection after transplantation. In Hong Kong, Prograf is regulated by the Department of Health and is only available with a physician’s prescription.
Tacrolimus suppresses the immune system by inhibiting the activity of calcineurin, an enzyme crucial for activating T-lymphocytes. By blocking calcineurin, tacrolimus reduces the production of interleukin-2 and other cytokines that drive the immune response. This dampened immune activity helps the body accept a transplanted organ and can also lessen immune-mediated inflammation in certain autoimmune conditions. The drug is taken orally, reaches peak blood concentrations within 1-3 hours, and has an elimination half-life of roughly 12 hours, although this can vary with liver function and other factors.
These indications are approved by the Hong Kong regulatory authorities and are supported by extensive clinical experience and peer-reviewed studies.
Prograf has been studied for several conditions that are not formally approved in Hong Kong:
Off-label use requires medical supervision and individualized risk assessment. Prograf is not approved for these conditions by the Hong Kong Department of Health.
If any of the above conditions apply, discuss them thoroughly with your healthcare provider before starting Prograf.
These effects are usually mild and may improve with dose adjustment.
If you experience any of these serious symptoms, seek medical attention promptly.
Patients should provide a full medication list-including over-the-counter drugs and herbal supplements-to their prescriber.
Regular follow-up with the transplant or rheumatology team is essential to balance efficacy and safety.
This article provides educational information about Prograf and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, you can travel with Prograf, but you should carry the prescription label and a copy of the prescribing doctor’s note. Some countries require documentation for controlled medicines, so check the destination’s customs regulations in advance.
Prograf tablets are imprinted with the strength (e.g., “0.5 mg”, “1 mg”, or “5 mg”) and the word “Prograf.” The exact font and color may vary by manufacturer, but the imprint is consistent across authorized supplies.
Tacrolimus is not a substance screened for in standard workplace drug tests. However, if a test includes immunosuppressant monitoring (rare), disclose your prescription to the testing authority.
There are no specific foods that must be avoided, but grapefruit and grapefruit juice can increase tacrolimus levels by inhibiting CYP3A4. It is safest to limit or avoid grapefruit while on this medication.
Steady-state concentrations are typically reached after 3-5 days of consistent dosing. Levels are checked after this period to confirm the new target range.
Yes, generic versions containing the same amount of tacrolimus are bioequivalent, but any change should be done under medical supervision to ensure stable blood levels.
Report the change to your physician promptly. Elevated blood pressure is a known side effect and may require dose adjustment or addition of antihypertensive medication.
Inactivated (flu shot) vaccines are generally safe for immunosuppressed patients. Live vaccines are contraindicated. Discuss vaccination timing with your healthcare provider.
Prograf is often priced higher than some generic tacrolimus alternatives due to brand positioning. However, pricing can vary by pharmacy and insurance coverage. For exact costs, consult local pharmacies or your insurer.
